Adam Feuerstein
Senior Writer at @statnews. I am the Night King of biotech. Data Are. Dogs rule. Said one analyst: The likes of Adam Feuerstein attack viciously.
Last synced from Twitter 127d ago
2020 STAT Summit
The 2020 STAT Summit is a virtual program from Nov. 16-19.
Inside the internal fight over Pinterest’s health misinformation policy
Pinterest’s battle against health misinformation has been just as much a fight inside the company’s own doors.
Can boosting the ‘bliss molecule’ help treat mental health conditions?
FAAH inhibitors have been tested in dozens of trials, only for each one to fail. But one company is going to give them another shot.
Adam Feuerstein
Can boosting the ‘bliss molecule’ help treat mental health conditions? An oft-failed idea gets another shot statnews.com/2020/10/27/can… via @damiangarde
128d
Hedge Funds’ Shot at Keeping Stock Investments Secret Fades
U.S. regulators are shelving a controversial plan to allow most hedge funds to keep their stock investments secret.
Covid-19 expert Akiko Iwasaki fights a different virus: sexism in science
To know virologist Akiko Iwasaki is to know that she is passionate about combatting sexism, power imbalance, and toxic behavior in academia.
No news on Pfizer’s Covid-19 vaccine is good news — and bad news
Pfizer and BioNTech are under a white-hot spotlight because their vaccine, by design, is likely to be the first to have any efficacy data.
1
Adam Feuerstein
No news on $PFE #Covid19 vaccine is good news — and bad news statnews.com/2020/10/27/no-… @matthewherper on this morning's freakout.
128d
Exact Sciences acquires liquid biopsy company Thrive for $2.15 billion
Exact Sciences acquired the liquid biopsy company Thrive Earlier Detection for $2.15 billion, the company said Tuesday.
Adam Feuerstein
Exact Sciences acquires liquid biopsy company Thrive for $2.15 billion statnews.com/2020/10/27/exa… via @sheridan_kate $EXAS
128d
Why did this biotech blow up? Because spinning bad data never works
The outcome of a Catabasis Pharma study is the end for its drug, and quite likely the entire company. But the writing was on the wall.
Adam Feuerstein
Why did this small biotech blow up? Because spinning bad drug data never works statnews.com/2020/10/27/why… The sad but evergreen lesson of $CATB
128d
Exact Sciences (EXAS) to Acquire Thrive Earlier Detection for Cash and Stock up to $2.15 Billion
Exact Sciences Corp. (Nasdaq: EXAS) and Thrive Earlier Detection Corp. ("Thrive"), a healthcare company dedicated to incorporating earlier cancer detection into routine medical care, today announced they have...
Catabasis Pharmaceuticals Announces Top-Line Results for the Phase 3 PolarisDMD Trial of Edasalonexent in Duchenne Muscular Dystrophy
Catabasis Pharmaceuticals Announces Top-Line Results for the Phase 3 PolarisDMD Trial of Edasalonexent in Duchenne Muscular Dystrophy
AstraZeneca CEO says participant had neurological symptoms, could be discharged today
AstraZeneca's CEO said in a private call with investors that the participant had symptoms consistent with a rare spinal inflammatory disorder.
Mirati results set new response bar for KRAS-blocking lung cancer drugs
A pill from Mirati Therapeutics designed to block the cancer protein KRAS shrank tumors in 45% of patients with advanced lung cancer.
Adam Feuerstein
$MRTX study results set new response bar for KRAS-blocking lung cancer drugs statnews.com/2020/10/25/mir… $AMGN
130d
Adam Feuerstein
Here are some slides from Dr. Janne’s presentation of the $MRTX adagrasib data.
My story: statnews.com/2020/10/25/mir… pic.twitter.com/eHEzIUbAB8
130d
Why approval of remdesivir to treat Covid-19 obscures scientific failures
STAT's Adam Feuerstein and Matthew Herper sat down to discuss the decision, and what it means for biotech and the battle against Covid-19.
2
Adam Feuerstein
Why the approval of remdesivir to treat #Covid19 obscures bigger scientific failures statnews.com/2020/10/23/why… This is what happens when @matthewherper calls me and asks, "What do you think?"
132d
Study: Universal mask use could save 130,000 lives by February - STAT
“Expanding mask use is one of the easy wins for the United States," said the lead author of the new study.
1
Adam Feuerstein
Universal mask use could save 130,000 U.S. lives by the end of February, new study estimates statnews.com/2020/10/23/uni… via @EricBoodman
132d
FDA express concern over emergency authorization of Covid-19 vaccines
The ageny may be exploring the idea of using expanded access — a more limiting program — in the early days of Covid vaccine rollouts.
Adam Feuerstein
FDA shows signs of cold feet over emergency authorization of #Covid19 vaccines statnews.com/2020/10/23/fda… via @HelenBranswell
132d
NY restaurant couple mistakenly served $2000 Mouton 1989 after ordering $18 Pinot - Decanter
A young couple at New York restaurant Balthazar were accidentally served a bottle of Mouton Rothschild 1989, listed at $2,000, after ordering an $18 Pinot
Listen: How FDA thinks about Covid vaccines & biotech's SPAC fascination
This week, we discuss a momentous FDA meeting about Covid-19 vaccines and why its lack of fireworks is heartening to public health experts.
3
Adam Feuerstein
BREAKING
BREAKING
BREAKING…
The incomparable @megtirrell is the new co-host of The Readout LOUD podcast!
Welcome, Meg! We’re super-excited!
133d
Democrats want to overhaul Warp Speed. But if Biden wins, should he?
Democrats have called for the ouster of the Warp Speed chief and an overhaul of the program. But if Biden wins, should he upend it?
Adam Feuerstein
Democrats want to fire Warp Speed’s Moncef Slaoui and overhaul the #Covid19 vaccine and drug program. But if Biden wins, should he? statnews.com/2020/10/22/sla… via @NicholasFlorko pic.twitter.com/2trcvYCUGK
133d
New rare disease gene therapy startup recruits former Sarepta executive
AavantiBio will seek to develop an experimental gene therapy to treat patients with Friedreich's Ataxia, a rare, inherited disease.
What to know about the pivotal FDA meeting on Biogen’s Alzheimer's drug
Here’s what you need to know about aducanumab, the controversy around it, and the issues that will take center stage at the FDA meeting.
Adam Feuerstein
A pivotal FDA meeting on $BIIB Alzheimer’s treatment is near. Here’s what you need to know statnews.com/2020/10/21/a-p… Remember when aducanumab was the most important thing in biotech? Even with Covid, the drug is still a really big deal. The FDA panel will be 🔥
134d